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hree populations of myogenic cells were isolated
from normal mouse skeletal muscle based on their
adhesion characteristics and proliferation behaviors.
Although two of these populations displayed satellite cell
characteristics, a third population of long-time proliferating
cells expressing hematopoietic stem cell markers was also
identiﬁed. This third population comprises cells that retain
their phenotype for more than 30 passages with normal
karyotype and can differentiate into muscle, neural, and
endothelial lineages both in vitro and in vivo. In contrast
to the other two populations of myogenic cells, the trans-
T
 
plantation of the long-time proliferating cells improved
the efﬁciency of muscle regeneration and dystrophin delivery
to dystrophic muscle. The long-time proliferating cells’ ability
to proliferate in vivo for an extended period of time,
combined with their strong capacity for self-renewal, their
multipotent differentiation, and their immune-privileged
behavior, reveals, at least in part, the basis for the improve-
ment of cell transplantation. Our results suggest that this novel
 
population of muscle-derived stem cells will signiﬁcantly
improve muscle cell–mediated therapies.
 
Introduction
 
Growth and repair of skeletal muscle in the postnatal stage are
normally initiated by the activation of a population of mononu-
cleated muscle precursors called satellite cells, which are located
beneath the basement membrane of muscle fibers (Schultz et
al., 1985; Bischoff, 1986). Based on their ability to repair in-
jured or damaged muscle fibers in the postnatal stage, satellite
cells were proposed as a population of muscle stem cells
(Bischoff, 1986; Stockdale, 1990; Schultz and McCormick,
1994). The differential behavior of the satellite cells both in
vitro and in vivo supports the evidence that satellite cells are
heterogeneous in nature (Schultz and McCormick, 1994;
Rantanen et al., 1995; Molnar et al., 1996). At least two popu-
lations of satellite cells, “fusing” and “nonfusing” satellite cells,
have been isolated from skeletal muscle tissue of different
species (Baroffio et al., 1996). A small population of satellite
cells that divide more slowly than the main population has also
been reported in mouse (Beauchamp et al., 1999) and rat
muscle cell cultures (Schultz, 1996). By using a quantitative
marking technique and the dynamics of myoblast transplanta-
tion, it was found that the majority of transplanted muscle cells
was eliminated shortly after transplantation and the newly
regenerated myofibers in the host were formed by the progeny
of a small percentage of the injected cells (Huard et al., 1994b;
Beauchamp et al., 1999). This result suggests that there may be
a unique subpopulation of stem cells within the satellite cell
population. Similarly, previous studies have reported that some
myoblasts become quiescent muscle precursors after implanta-
tion into the skeletal muscle of mdx mice, and persist for 
 
 
 
1 yr
after implantation (Morgan et al., 1994; Gussoni et al., 1997;
Smith and Schofield, 1997). These results, taken together,
suggest that satellite cells are heterogeneous and that a small
subpopulation of these cells displays stem cell characteristics.
More substantial evidence of the existence of pluripotent
stem cells in mouse skeletal muscle was recently reported. A side
population (SP)* of cells was isolated from mouse muscle by
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, which previously was used to isolate hematopoietic
stem cells (Gussoni et al., 1999). SP cells derived from both
muscle and bone marrow were shown to be capable of differen-
tiating into multiple lineages after intravenous transplantation
into host mice (Gussoni et al., 1999). Jackson et al. (1999) also
showed that a population of muscle-derived cells exhibited a re-
markable capacity for hematopoietic differentiation after intra-
venous implantation into lethally irradiated mice. Importantly,
a population of muscle cells derived from mice that were defi-
cient in Pax7, a transcription factor expressed in satellite cells,
exhibited a strong capacity for differentiation into the hemato-
poietic lineage but lacked the ability to differentiate into the
myogenic lineage (Seale et al., 2000). This suggests that satellite
cells and the muscle-derived SP cells displaying a hematopoietic
potential are distinct cell populations. Additionally, recent
studies have indicated that the progenitor cells isolated from
bone marrow (Ferrari et al., 1998; Gussoni et al., 1999), the
embryonic vasculature (De Angelis et al., 1999), the neuronal
compartment (Clarke et al., 2000; Galli et al., 2000), and vari-
ous mesenchymal tissues (Young et al., 2001a,b) can also dif-
ferentiate into the myogenic lineage, suggesting that stem cells
from other sources could contribute to muscle regeneration.
Therefore, additional experiments are required to elucidate
whether multiple types of muscle-derived stem cells (MDSC)
exist and whether they display a differential ability to regener-
ate skeletal muscle.
Separation and characterization of muscle stem cells re-
main critical because of the cells’ rarity (Schultz, 1996;
Beauchamp et al., 1999; Gussoni et al., 1999; Lee et al.,
2000) and the lack of specific markers to identify myogenic
cells at very early stages of development (Dominov et al.,
1998; Miller et al., 1999). The CD34 antigen, a transmem-
brane cell surface glycoprotein, has been identified and char-
acterized as a hematopoietic stem cell marker in different
species, including mice (Krause et al., 1994; Fennie et al.,
1995; Morel et al., 1996). More recently, a population of
CD34
 
 
 
 satellite cells was found in mouse skeletal muscle
(Beauchamp et al., 2000; Lee et al., 2000), suggesting that
the CD34 antigen is also expressed in some myogenic cells.
If early myogenic cells display stem cell characteristics, they
might also express similar surface antigens, as observed in
murine hematopoietic stem cells. Sca-1, a protein expressed
in murine hematopoietic stem cells (Nakauchi et al., 1999),
may also be used as a muscle stem cell marker. The identifi-
cation of the markers expressed in various types of muscle-
derived cells will likely be helpful in delineating this small
population of MDSC in mice.
We recently reported (Qu et al., 1998) the isolation (using
the preplate technique) of a specific population of muscle-
derived cells that could avoid early cell death after transplan-
tation into skeletal muscle. We have also reported (Lee et al.,
2000) the presence of two populations of myogenic cells,
cells expressing m-cadherin and cells expressing CD34, in
the skeletal muscle of normal mice, residing between the
basal lamina and plasma membrane. Cloned cells isolated
from the CD34
 
 
 
 population could differentiate into differ-
ent lineages and, more importantly, could improve both
muscle regeneration and bone healing in vivo (Lee et al.,
2000). In the present study, three populations of muscle-
derived cells were isolated from normal mice according to
 
their adhesion characteristics and proliferation behaviors: the
early preplate cells (EP); the late preplate cells (LP); and a
rare population of long-time proliferating cells that were de-
rived from primary LP cultures (see Materials and methods).
The levels of expression of stem cell and myogenic cell
markers in these various populations of purified myogenic
cells were investigated. The cell populations’ ability to im-
prove the efficiency of myoblast transplantation in dystro-
phin-deficient mdx mice was tested by investigating their ca-
pacity for self-renewal, long-time proliferation, multipotent
differentiation, and immune-privileged behaviors. Our re-
sults suggest that the EP and LP cells are two populations of
satellite cells, whereas the rare population of cells capable of
high proliferation represents a novel type of pluripotent
MDSC.
 
Results
 
Proliferation ability of MDSC and EP cells
 
We have only characterized the proliferation behavior of
MDSC and EP cells, because most of the LP cells did not
proliferate and died within 1–2 wk of culturing. These two
populations of muscle-derived cells (EP and MDSC) dis-
played differences in cell culture proliferation behaviors. EP
cells remained quiescent (EPq) during the first 1–3 d after
initial seeding and then divided three to five times in prolif-
eration medium (PM) (activated EP cells [EPa]), with an av-
erage division time of 12.6 h (
 
 
 
 3.9, SD; 
 
n
 
 
 
  
 
3 separated
cultures). Afterward, 
 
 
 
80% of the EP cells in the culture
fused into myotubes, even when cultivated in PM or at a low
confluence (
 
 
 
30%). As mentioned above, the LP cells are
distinguished from EP cells by their slow division and their
lack of fusion. Due to the continuity of the preplate tech-
nique (see Materials and methods), we cannot exclude the
possibility that some of the LP cells were isolated from a
nonfusing progeny of EP cells, as previously described for
satellite cells (Baroffio et al., 1996). The MDSC could di-
vide for more than 30 passages in PM with an average divi-
sion time of 15.1 h (
 
 
 
 2.3, SD; 
 
n
 
 
 
  
 
3 separated cultures).
In addition, we have observed that MDSC preserve their
normal karyotype with culturing (30 passages). The normal
diploid number of chromosomes (2
 
n
 
) seen in mice is 40. We
randomly examined 28 cells in MDSC culture and found
that the majority of cells counted (24/28) had a diploid
number of 40, with three missing a single chromosome and
one gaining one chromosome. The few aneuploid cells
found within the MDSC are probably due to normal tissue
culture artifact (Wenger et al., 1984; Barch, 1991).
 
The expression of stem cell and early myogenic cell 
markers in the populations of muscle-derived cells
 
Immunostaining to colocalize the stem cell antigen Sca-1, the
myogenic antigen desmin, and Hoechst (which reveals nuclei)
was performed on EP and MDSC cultures in vitro (Fig. 1, a
and b). In the EP culture (Fig. 1 a), 
 
 
 
90% of the cells expressed
desmin (green), and 30–40% of the cells coexpressed a hetero-
geneous, high level of Sca-1 (red, arrow). In the MDSC culture
(Fig. 1 b), only 30–40% of the MDSC were desmin
 
 
 
 (green,
arrow), whereas 
 
 
 
90% expressed Sca-1 (red, arrowhead). To
evaluate the relative percentages of CD34
 
 
 
 and Sca-1
 
 
 
 cells in 
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the two cell populations, flow cytometry was also performed
(Fig. 1, c and d). In the EP culture (Fig. 1 c), 83% of the cells
expressed CD34, and 55% of the cells coexpressed Sca-1/
CD34. In the MDSC culture (passage 10), 79% of the cells ex-
pressed CD34, and 60% of the cells coexpressed Sca-1/CD34
 
(Fig. 1 d). In contrast to the EP culture, the MDSC culture
contained a population (10%) of cells that were Sca-1
 
 
 
 and
CD34
 
 
 
. Finally, RT-PCR for CD34 (Fig. 1 e) and MyoD, an
early myogenic marker (Fig. 1 f), further validated that both EP
cells and MDSC expressed CD34 and MyoD.
The phenotypes of these different populations of muscle-
derived cells determined by immunochemistry, RT-PCR,
and flow cytometry are summarized in Table I. Two differ-
ent populations of EP cells were characterized: relatively qui-
escent nondividing (EPq) cells and dividing (EPa) cells. The
nondividing EP cells were a population that had been culti-
vated for 3 d from initial seeding, whereas the dividing EP
cells had been cultivated for 5 d. The EPq cells displayed the
phenotype desmin
 
 
 
, CD34
 
 
 
, Bcl2
 
 
 
, Sca-1
 
 
 
, MyoD
 
 
 
/
 
 
 
,
myogenin
 
 
 
/
 
 
 
, and m-cadherin
 
 
 
/
 
 
 
, whereas the EPa cells dis-
played the same characteristics for desmin, MyoD, myoge-
nin, Bcl2, and m-cadherin, but were CD34
 
 
 
/
 
 
 
 and Sca-1
 
 
 
/
 
 
 
.
This result demonstrates that the cultivation of a similar
population of cells for an extra 2 d may alter the expression
pattern of myogenic and stem cell markers. The LP cells
displayed the phenotype desmin
 
 
 
/
 
 
 
, CD34
 
 
 
/
 
 
 
, Sca-1
 
 
 
/
 
 
 
,
MyoD
 
 
 
/
 
 
 
, myogenin
 
 
 
/
 
 
 
, and m-cadherin
 
 
 
/
 
 
 
, whereas the
MDSC were desmin
 
 
 
/
 
 
 
, CD34
 
 
 
, Bcl2
 
 
 
, Sca-1
 
 
 
, and m-cad-
herin
 
 
 
. All of the cell populations were found by flow cy-
tometry to be negative for both c-Kit and CD45, eliminat-
ing their potential hematopoietic origin.
Although the two populations of proliferating myogenic
cells (EP cells and MDSC) displayed similar patterns of ex-
pression of myogenic and stem cell markers, differences in
the levels of Sca-1 and CD34 expression and the relative per-
 
Table I. 
 
The phenotypes of EP, LP, and long-time proliferating cells 
(MDSC) investigated by immunocytochemistry, flow cytometry, 
and RT-PCR
Markers EPq EPa LP MDSC
Imm Imm Flow RT Imm Imm Flow RT
 
CD34
 
                       
 
Sca-1
 
         
 
ND
 
         
 
ND
c-Kit ND ND
 
 
 
ND
 
    
 
ND
CD45 ND ND
 
 
 
ND ND ND
 
 
 
ND
Desmin
 
  
 
ND ND
 
       
 
ND ND
Bc12
 
  
 
ND
 
 
 
ND
 
 
 
ND
 
 
 
MNF ND
 
 
 
ND
 
 
 
ND
 
 
 
ND
 
 
 
MyoD
 
       
 
ND
 
     
 
ND ND
 
 
 
Myogenin
 
       
 
ND
 
     
 
ND ND ND
m-cadherin
 
     
 
ND ND
 
     
 
ND ND
EP and LP cells were dissociated from the hindlimb muscle of normal
newborn mice and separated by their adhesion characteristics (see
Materials and methods for details). Two populations of EP cells were used
here: the EP cells after 3 d of culturing (EPq, relatively quiescent) and the EP
cells after 5 d of culturing (EPa, activated). The LP cells took 5–7 d to attach
to flasks and were cultured for an additional 4 d. MDSC were isolated from
a small population of long-time proliferating cells derived from the LP cells.
In immunochemistry and flow cytometry, 
 
 
 
, 
 
 
 
95% of the cells were
positive; 
 
   
 
, 40–80% of the cells were positive; 
 
   
 
, 10–30% of the cells
were positive; 
 
 
 
, 
 
 
 
5% of the cells were positive. Flow, flow cytometry;
Imm, immunochemistry; RT, RT-PCR.
Figure 1. Phenotypes of EP cells and 
MDSC in cultures and in normal muscle 
sections. (a and b) Immunostaining 
revealed that in the EP culture (a), most of 
the cells are desmin
  (green, arrowhead), 
and some cells coexpressed a high level 
of Sca-1 (red, arrow). In contrast, many 
cells in the MDSC culture (b) expressed 
Sca-1 (red, arrowhead), but only 30–40% 
of these cells expressed desmin (green, 
arrow). (c and d) Flow cytometry showed 
that in the EP culture (c), 83% of the cells 
expressed CD34, and 55% of the cells 
coexpressed CD34/Sca-1. In the MDSC 
culture (d), 79% of the cells expressed 
CD34, and 60% of the cells coexpressed 
CD34/Sca-1. Unlike the EP culture (c), 
the MDSC culture (d) contained a popu-
lation (10%) of cells that were Sca-1
  and 
CD34
 . (e and f) RT-PCR for CD34 (e) 
and MyoD, an early stage marker of myo-
genesis (f), showed that the two popula-
tions (EP cells and MDSC) express both 
CD34 and MyoD. M, markers; C, control 
MDSC without reverse transcriptase. 
(i and j) Immunostaining of muscle cross 
sections prepared from normal mice 
showed that Sca-1–expressing cells 
(g, red) were found beneath the basement membrane, as revealed by laminin staining (h–j, green). The arrowhead in j is showing the 
Sca-1–expressing cells, whereas the arrow is showing the basal lamina expressing laminin. The nuclei were revealed by Hoechst staining (g, i, and j). 
(k–m) Colocalization of m-cadherin (Cy5, red), Sca-1 (PE, red), laminin (FITC, green), and nuclei (blue) confirmed that the Sca-1–expressing cells 
(k, arrow) did not colocalize with m-cadherin
  cells (l, arrow). Similarly, the m-cadherin
  cells (m, arrowhead) did not colocalize with Sca-1–
expressing cells (n, arrowhead). Notice that the capillaries are also Sca-1
  (m and n, arrows). Bars: (a, b, and k–n) 50  m; (g–i) 25  m; (j) 100  m. 
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centages of desmin-expressing cells were still observed be-
tween the populations. Unlike EP cells, most MDSC
(
 
 
 
60%) do not express the myogenic marker desmin, and a
small population (10%) of these cells is Sca-1
 
 
 
/CD34
 
 
 
; this
latter characteristic also is found in primary hematopoietic
stem cells (Nakauchi et al., 1999).
Based on these in vitro results, we hypothesized that the
different populations of myogenic cells expressing these par-
ticular phenotypes might also be found in skeletal muscle in
vivo. Because the quiescent EP cells were m-cadherin
 
 
 
/
 
 
 
,
CD34
 
 
 
, Sca-1
 
 
 
, and Bcl2
 
 
 
, whereas the MDSC were
m-cadherin
 
 
 
, CD34
 
 
 
, Sca-1
 
 
 
, and Bcl2
 , we investigated
these markers by immunohistochemistry to detect the pres-
ence of these two types of myogenic cells in normal muscle
sections. We already have reported a population of CD34
 
and Bcl2
  cells beneath the basement membrane in normal
skeletal muscle (Lee et al., 2000); in this study, we have fur-
ther investigated whether Sca-1
  cells also could be located
beneath the basal lamina of muscle fibers. We colocalized by
immunohistochemistry Sca-1, laminin, and Hoechst/nuclei
(Fig. 1, g–j). Sca-1 was revealed by Cy3 immunofluores-
cence (Fig. 1 g, red), whereas laminin was detected by FITC
immunofluorescence (Fig. 1 h, green). As with CD34
  and
Bcl2
  cells in normal muscle cross sections (Lee et al.,
2000), the colocalization of Sca-1/laminin/nuclei (Hoechst/
blue) revealed that the cells expressing Sca-1 were also lo-
cated beneath the basement membrane (Fig. 1, i and j). Fur-
ther staining to colocalize Sca-1(phycoerythrin [PE], red),
m-cadherin (Cy5, red), laminin (FITC, green), and nuclei
(Hoechst, blue) confirmed that the Sca-1
  cells (Fig. 1 k,
red, arrow) did not colocalize with m-cadherin (Fig. 1 l, ar-
row), and the m-cadherin–expressing cells (Fig. 1 m, arrow-
head) did not colocalize with Sca-1 (Fig. 1 n, arrowhead). In
muscle tissue, the majority of blood vessels and capillaries
were also Sca-1
 , were often surrounded by basement mem-
brane, and did not colocalize with Hoechst (Fig. 1, m and n,
arrow). Some Sca-1
  cells were observed outside of the base-
ment membrane (unpublished data), and they probably de-
rived from circulating blood. We also counted the number
of m-cadherin and Sca-1
  cells beneath the basal lamina in
15 gastrocnemius muscle sections from three normal mice.
The ratio of Sca-1
  to m-cadherin
  cells was found to be
less than 1:100 (4:600). These results support our previous
findings (Lee et al., 2000), indicating the existence of dis-
tinct populations of muscle progenitor cells located beneath
the basal lamina of normal myofibers.
Long-term restoration of dystrophin 
by MDSC transplantation
The purification of different populations of muscle-derived
cells led us to investigate their role in muscle regeneration.
Because both EP cells and MDSC showed the ability to pro-
liferate in culture, an important criterion for cell transplan-
tation, we focused our cell transplantation experiments on
these two populations of cells. We transplanted the same
number of EP cells and MDSC (3–4   10
5) from normal
newborn mice (C57BL/6J) into the m. gastrocnemius of
mdx mice (C57BL/10ScSn DMD
mdx/J; 6–8 wk old). We
detected a large number of dystrophin
  myofibers in the
MDSC-injected muscle (Fig. 2 a), in contrast to the EP cell–
injected muscle (Fig. 2 b), at 10 d after transplantation. The
MDSC-injected muscle contained many more small myofi-
bers (Fig. 2 c) when compared with the EP cell–injected
muscle (Fig. 2 d), suggesting that the injected MDSC may
possess a higher proliferative ability in vivo than EP cells, as
observed in vitro. Moreover, we observed many dystrophin
 
myofibers at 30 d and 90 d (Fig. 2 e) after transplantation of
the MDSC, but only a few dystrophin
  myofibers were de-
Figure 2. Dystrophin expression in 
mdx skeletal muscle after MDSC and EP 
cell transplantation. (a–g) Many 
dystrophin
  myofibers were detected in 
both MDSC-injected muscle (a) and the 
EP cell–injected muscle (b) at 10 d after 
injection; however, the number of 
dystrophin
  myofibers was significantly 
higher in the MDSC-injected muscle (g). 
Boxed regions in a and b are enlarged in 
c and d, and show that the MDSC-
injected muscle contained many more 
small dystrophin
  myofibers (c) than the 
EP cell–injected muscle (d). Many 
dystrophin
  myofibers were still 
observed at 90 d after injection of MDSC 
(e), whereas very few were observed in 
EP cell–injected muscles (f). The number 
of dystrophin
  myofibers was significantly 
higher in the MDSC-injected muscle 
than in the EP cell–injected muscle at 
all time points analyzed (g; *P   0.01,
n   3–5 animals/group). (h–j) MDSC-
injected muscle sections containing 
dystrophin staining (red) were also counterstained with Hoechst (blue) to reveal the location of nuclei. Many dystrophin
  myofibers were 
centronucleated at 30 d after implantation (h), but a significant decrease in the number of centronucleated myofibers occurred by 90 d after 
injection (i). We observed no difference in the percentage of centronucleated myofibers between injected and noninjected areas at 10 d after 
injection (j). However, at 30 and 90 d after transplantation, the number of centronucleated myofibers was significantly lower (*P   0.01, n   3 
muscles/condition) at the injected site than at the noninjected site. Bars: (a and b) 500  m; (c and d) 50  m; (e and f) 150  m; (h and i) 25  m. Identification of muscle stem cells in mice | Qu-Petersen et al. 855
tected in EP cell–injected muscle at 30 d and 90 d after in-
jection (Fig. 2 f). Despite injection of the same number of
transplanted cells, the number of dystrophin
  myofibers was
approximately five times higher in the MDSC-injected mus-
cle than in the EP cell–injected muscle at 10 d after injection
(2178.8   628.5, n   4, in the MDSC-injected muscle
vs. 420.4   152.7, n   5, in the EP cell–injected muscle)
(Fig. 2 g). At 30 and 90 d after transplantation, 10 times
more dystrophin
  myofibers were found in MDSC-injected
groups than in EP cell–injected groups (1435.8   312.5,
n   4, vs. 128.7   37.8, n   3 at day 30; 1834.0   489.9
vs. 139.0   20.0, n   3 at day 90) (Fig. 2 g).
To further examine the effect of MDSC transplantation on
the histology of the dystrophic muscle, we investigated the
number of dystrophin
  myofibers that were centronucleated at
10, 30, and 90 d after transplantation. The percentage of cen-
tronucleated myofibers revealed by Hoechst (blue) was investi-
gated in both the injected and noninjected areas of the trans-
planted muscles; 250–950 myofibers per site were analyzed
(Fig. 2, h–j). The injected area was easily recognizable by the
presence of numerous dystrophin
  myofibers. The percentage
of centronucleated myofibers was not significantly different be-
tween the noninjected (NI) and injected (I) sites at 10 d after
transplantation (Fig. 2 j), but a significant decrease in the per-
centage of centronucleated myofibers was observed between
noninjected and injected areas at 30 d (NI, 67.1%   7.6, vs. I,
46.5%   7.3, n   4) (Fig. 2, h and j) and 90 d after injection
(NI, 71.3%   1.1, vs. I, 16.3%   4.1, n   3) (Fig. 2, i and j).
These results suggest that the delivery of dystrophin via trans-
plantation of MDSC can restore, at least in part, the histology
of dystrophic muscle for up to 3 mo after transplantation.
The unique ability of the novel population of MDSC to
improve both the extent of muscle regeneration and the per-
sistence of dystrophin delivery within dystrophic mice when
compared with EP cells led us to investigate the mechanism
by which these cells improve cell transplantation. We there-
fore tested (a) the self-renewal and multipotent differentia-
tion ability of these muscle-derived cells and (b) the cells’
immune-privileged behavior after transplantation in vivo.
The self-renewal ability of MDSC in vitro and in vivo
To examine the self-renewal ability of MDSC, we first inves-
tigated whether the high percentages of CD34
  and Sca-1
 
cells in the MDSC population could be maintained for a pe-
riod of time with culturing in vitro (10 and 30 passages) and
whether this phenotype could be preserved between cloned
and subcloned MDSC. High percentages of CD34
  and Sca-
1
  cells in the MDSC culture (at passage 30) were observed
by flow cytometry; 77% of the cells were CD34
 , 57% were
CD34
 /Sca-1
 , and 8% were CD34
 /Sca-1
  (Fig. 3 a),
which is very similar to the MDSC at passage 10 (Fig. 1 d).
Moreover, these similarities also were observed in the MDSC
clone cells (unpublished data), of which 73% were CD34
 ,
62% were CD34
 /Sca-1
 , and 11% were CD34
 /Sca-1
 , as
well as in some subclones of MDSC cloned cells (Fig. 3 b), of
which 91% were CD34
 , 59% were CD34
 /Sca-1
 , and 5%
were CD34
 /Sca-1
 . These results indicate that MDSC have
the capacity for self-renewal in vitro.
The self-renewal capacity of MDSC in vivo was tested fur-
ther by transducing both MDSC and EP cells with a retrovi-
rus carrying the lacZ reporter gene and injecting them into
the m. gastrocnemius of mdx mice. LacZ
  muscle-derived
cells were isolated from the EP cell– (unpublished data) and
Figure 3. Self-renewal ability of MDSC and EP cells. (a and b) Flow 
cytometric analysis of CD34 and Sca-1 expression of MDSC (at passage 
30) (a) and subcloned MDSC (b). Of the MDSC at passage 30, 77% 
were CD34
 , 57% were CD34
 /Sca-1
 , and 8% were CD34
 /Sca-1
 , 
which is very similar to observations of the MDSC at passage 10 
(Fig. 2 d). A subclone culture displayed a similar pattern of phenotypes: 
91% of the cells were CD34
 ; 59% were CD34
 /Sca-1
 ; and 5% were 
CD34
 /Sca-1
  (b). (c and d) EP cells and MDSC were transduced with 
a retrovirus encoding for the lacZ reporter gene and injected into mdx 
hindlimb muscle. LacZ
  muscle-derived cells (c, arrow) were isolated 
from the injected dystrophic muscles 30 d after transplantation. Up to 
five times more lacZ
  cells were observed in the cultures prepared 
from the MDSC-injected muscle than in those prepared from the EP 
cell–injected muscle (d; *P   0.05, n   3 cultures). (e–g) To reveal 
the donor-derived satellite cells, some MDSC-injected muscles 
were sectioned, and  -galactosidase (red) was colocalized with 
m-cadherin (green) and Hoechst (blue) by immunohistochemistry. 
 -Galactosidase
  cells (e, arrowheads) expressing m-cadherin 
(f, arrowheads), which colocalized with nuclei (g, arrowheads; triple 
exposure), were detected in transplanted muscle. (h) We further 
performed immunochemistry to evaluate the number of m-cadherin
  
and Sca-1
  cells in MDSC-injected muscle at 90 d after injection. The 
number of m-cadherin
  and Sca-1
  cells was higher (*P   0.01, n   3 
muscles/experiment) in the injected site (dystrophin
  myofibers) 
than in the noninjected site (dystrophin
  myofibers). (Panel g) B, 
 -galactosidase staining; M, m-cadherin staining; H, Hoechst staining. 
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MDSC-injected muscles (Fig. 3 c) of dystrophic mice at 1
mo after transplantation. The number of lacZ
  cells was
counted in each culture in 20 fields at 200  magnification
(three animals per group). The number of lacZ
  cells de-
rived from the MDSC-injected muscles was significantly
higher than the number of lacZ
  cells derived from the EP
cell–injected muscles (226.3   81.0 vs. 43.0   8.7, n   3,
P   0.05) (Fig. 3 d). This suggests that transplantation of
both EP cells and MDSC resulted in the formation of do-
nor-derived muscle progenitors, but that the MDSC were
more efficient than the EP cells at generating muscle pro-
genitors in the transplanted mdx muscles. To further con-
firm the ability of MDSC to replenish muscle progenitors,
some of the MDSC-injected muscles were sectioned and
stained with  -galactosidase and m-cadherin by immunocy-
tochemistry (Fig. 3, e–g). The  -galactosidase
  cells (Fig. 3
e, red) expressing m-cadherin (Fig. 3 f, green) were indeed
colocalized within the injected muscles at 3 mo after trans-
plantation (Fig. 3 g), demonstrating that the MDSC con-
tributed to the replenishment of the satellite cell compart-
ment in the injected skeletal muscle.
Finally, the number of m-cadherin
  and Sca-1
  cells in
the injected areas was monitored at 90 d after injection and
compared with the noninjected areas. Sca-1
  cells lying be-
neath the basal lamina were determined by colocalizing
Sca-1, laminin, and nuclei. The injected sites were revealed
by dystrophin
  myofiber; the numbers of Sca-1
  and
m-cadherin
  cells in five fields of the injected and non-
injected areas were monitored at 200  magnification. In-
terestingly, the injected areas contained five times more
m-cadherin
  cells than the noninjected areas (I, 26.7   1.2,
vs. NI, 5.3   1.5, P   0.05, n   3 per group) (Fig. 3 h). Sim-
ilarly, Sca-1
  cells were found in the injected areas, whereas
no Sca-1
  cells could be detected in the noninjected areas an-
alyzed (5.0   1.0 vs. 0, n   3). These results provide further
evidence that the injected MDSC contribute to the replenish-
ment of myogenic progenitors (i.e., both m-cadherin– and
Sca-1–expressing cells) in the transplanted muscles.
Immune-privileged behavior of MDSC 
in transplanted muscle
To investigate whether the improved transplantation capacity
of the MDSC was related to a potential immune-privileged be-
havior of the injected cells, immunohistochemical staining to
reveal CD4 and CD8 T lymphocytes was performed on mus-
cles injected with EP cells and MDSC. By 10 d after injection
of the EP cells, both CD4 (Fig. 4 b, arrowhead) and CD8 (Fig.
4 c, arrowheads) lymphocytes had infiltrated the injected site,
which was revealed by the detection of dystrophin
  myofibers
and green fluorescent microspheres (Fig. 4 a) in the trans-
planted muscles (n   4). We incubated the fluorescent micro-
spheres with the cells before injection in order to follow their
fate after transplantation. At 30 d after injection, we still ob-
served some CD4
  cells (Fig. 4 d, arrowhead) in the muscles
(n   4) into which EP cells were transplanted; consequently,
we observed a dramatic decrease in the number of dystrophin
 
myofibers (Fig. 4 e). In contrast, at 30 and 90 d after injection,
we detected CD4
  and CD8
  cells in only half of the MDSC-
injected muscles (3:6). More importantly, we observed a com-
plete absence of CD4
  and CD8
  cells in the injected area of
some MDSC-injected muscles, despite the presence of a large
number of dystrophin
  myofibers at 1 mo after injection (Fig.
4, f and g).
We quantitated the number of infiltrating lymphocytes in
the EP cell– and MDSC-injected muscle and compared the
results among the different groups. The number of CD4
Figure 4. Detection of CD4 and CD8 lymphocytes in transplanted 
muscles and characterization of MHC-1 expression on MDSC and 
EP cells. (a–c) Immunostaining for dystrophin (dys; a), CD4 (b), and 
CD8 (c) cells was performed in muscle serial sections prepared from 
EP cell–injected muscles. By 10 d after injection (EP/D10), we 
detected both CD4 (b, arrowhead) and CD8 (c, arrowheads) 
lymphocytes in the injected area, as revealed by the green beads 
and the presence of numerous dystrophin
  myofibers (a–c). Stars 
in a–c indicate the same muscle fiber in serial muscle sections. (d–g) 
We also performed immunostaining to colocalize CD4 (red) and 
dystrophin (green) in MDSC- and EP cell–injected muscles, which 
were counterstained with Hoechst (blue) at 30 d after injection 
(D30). We observed some CD4
  cells in the EP cell–transplanted 
areas (d, arrowhead) in mdx muscles. In these areas, we also ob-
served a dramatic decrease in the number of dystrophin
  myofibers 
(e). In contrast, we detected an absence of CD4
  cells in the MDSC-
injected muscle (f) despite the presence of a large number of 
dystrophin
  myofibers at 30 d after transplantation (g). In e and g, 
the letters C, D, and H represent the colocalization of CD4, 
dystrophin, and Hoechst. The stars in f and g show the same 
myofibers. (h and i) We analyzed the percentage of MHC-1–
expressing cells on the MDSC and EP cell populations by flow 
cytometry. The MDSC were almost completely negative (0.5%) for 
the MHC-1 (i), whereas 69.3% of the EP cells were positive for 
MHC-1 (h). Bars, 100  m. Identification of muscle stem cells in mice | Qu-Petersen et al. 857
and CD8 lymphocytes was monitored in four muscle sec-
tions of each injected animal at 30 d after injection. We ob-
served that the number of CD4 and CD8 lymphocytes was
significantly lower in the MDSC-injected muscle than in the
EP cell–transplanted muscles (CD4, 10.0   3.7 in MDSC,
n   4, vs. 48   13.3 in EP, n   3; CD8, 5   3.5 in
MDSC, n   4, vs. 48.7   13.3 in EP, n   3). There was a
significantly lower number of CD4 and CD8 lymphocytes
within the injected MDSC than within the EP cells.
In an attempt to elucidate the mechanism by which
the MDSC display this immune-privileged behavior, the
MDSC and EP cells were tested for the expression of the
major histocompatibility complex class 1 (MHC-1), the an-
tigens that are mainly responsible for rejection (Hall et al.,
1984; Milton and Fabre, 1985; Mason and Morris, 1986).
It has been observed that the MHC-1 is strongly expressed
in myoblasts (Roy et al., 1991) and that the MHC-1 expres-
sion on target cells is a prerequisite for antigen-specific
T cell–mediated cytotoxicity (Emslie-Smith et al., 1989).
Therefore, the expression of MHC-1 on the MDSC and EP
cells was determined by flow cytometry. Surprisingly, the
MDSC were almost completely negative (0.5%) for the
MHC-1 (Fig. 4 i), whereas 69.3% of the EP cells were
found to be positive for the MHC-1 (Fig. 4 h). These results
suggest that the improved transplantation capacity of the
MDSC may be attributed to their inability to trigger infil-
tration of activated lymphocytes because of their low expres-
sion of MHC-1, which would eventually play a role in the
immune rejection of the transplanted cells.
The influence of growth factors on the MDSC
To investigate whether the MDSC could differentiate into
other lineages, the MDSC and two MDSC subclones
(msc1and msc3) were stimulated with nerve growth factor
(NGF) for 5 d, and their expression of 2 ,3 -cyclic nucle-
otide 3 -phosphohydrolase (CNPase) was analyzed by im-
munochemistry. CNPase is a myelin-associated enzyme that
is a constituent of both the oligodendrocyte progenitor cells
in the central nervous system and Schwann cells in the pe-
ripheral nervous system (Sprinkle et al., 1985). The number
of CNPase
  cells was counted at 200  magnification in five
fields, and a total of 452–1020 cells were counted for each
condition. An absence of CNPase-expressing cells was ob-
served in the MDSC culture before stimulation (Fig. 5 a).
However, 1.1% of the cells became CNPase
  when incu-
bated in NGF-supplemented medium (10 ng/ml) for 5 d
(Fig. 5, b and c). Interestingly, CNPase
  cells were detected
in msc1 and msc3 cultures without NGF stimulation. How-
ever, after stimulation with NGF, the number of CNPase
 
cells increased by 0.7% in the msc3 culture and by 2.1% in
the msc1 culture (Fig. 5 c).
A similar method was used to analyze the expression of
von Willebrand factor (vWF), an endothelial cell marker
(Mukai et al., 1980), in the MDSC after stimulation with
vascular endothelial growth factor (VEGF). vWF
  cells were
detected in the MDSC culture without VEGF stimulation,
but their number increased in the presence of this growth
factor (by 16% with 15 ng/ml and by 21% with 25 ng/ml)
(Fig. 5 d). At the same time, the number of desmin
  cells
decreased in the MDSC culture when stimulated with
VEGF (Fig. 5 d). This is in accordance with our recent ob-
servation that a subclone of MDSC (mc13), when cultivated
in medium supplemented with rhBMP-2 (an osteogenic fac-
tor) for 6 d (Lee et al., 2000), displayed a significant decrease
in the number of desmin
  cells while acquiring the ability to
express alkaline phosphatase (a preosteoblast marker).
Multipotential differentiation of MDSC in vivo
To further validate these in vitro findings, cloned MDSC
devoid of NGF or VEGF stimulation were genetically en-
gineered to express the lacZ reporter gene (nuclear loca-
tion), and were injected into the m. gastrocnemius of mdx
mice. By 10 d after injection, a large number of myofibers
containing lacZ
  nuclei was observed in the injected dys-
trophic muscle (Fig. 6 a-1). Additionally, some of the
lacZ
  nuclei were found in vascular-like (Fig. 6 a-2, ar-
Figure 5. Multipotent differentiation of MDSC in vitro. (a–c) 
Immunostaining was performed on MDSC and the subclones of 
MDSC with or without stimulation by NGF. MDSC without 
stimulation did not express CNPase (a), whereas some cells became 
CNPase
  in the presence of NGF-supplemented (10 ng/ml) medium 
for 5 d (b). Hoechst staining showed the total number of cells in 
culture (a and b). Interestingly, we detected CNPase
  cells in two 
of the subclone cultures, msc1 and msc3, before NGF stimulation 
(c). However, the percentage of CNPase
  cells was increased in all 
cell populations when incubated with NGF-supplemented medium 
for 5 d (c). (d) We also detected vWF
  MDSC without VEGF 
stimulation, and the percentage of vWF
  cells increased in the 
presence of VEGF-supplemented medium (15 and 25 ng/ml). We 
also observed that the number of desmin
  cells decreased after 
stimulation with VEGF. Bar, 50  m.858 The Journal of Cell Biology | Volume 157, Number 5, 2002
rowheads) and peripheral nerve–like structures (Fig. 6 a-3,
arrow). Arrowheads show the border of the nerve-like
structure (Fig. 6 a-3). By 25 d after transplantation, lacZ
 
nuclei were found in the endothelium of well-differenti-
ated blood vessels (Fig. 6 b-1, arrow), as defined by both
morphology and vWF immunostaining (Fig. 6 b-2).
LacZ
  nuclei were also found in the Schwann cells of
well-differentiated peripheral nerve (Fig. 6 c, arrow) in
transplanted muscle at 25 d after implantation. To con-
firm the nature of these various differentiated cell types,
colocalization of  -galactosidase/vWF/Hoechst by immu-
nochemistry was performed on muscle section prepared
from MDSC-injected muscles at 25 d after transplanta-
tion (Fig. 6, d-1–d-3).  -Galactosidase
  nuclei (green
fluorescence) were observed in vWF
  (red fluorescence)
structure (Fig. 6 d-1), and costained with Hoechst (Fig. 6,
d-2 and d-3). Moreover, after transplantation of green flu-
orescent protein (GFP)–expressing MDSC (Fig. 6, e-1–
e-3), some peripheral nerve structures displaying CNPase
immunoreactivity (Fig. 6 e-1) were colocalized with GFP-
expressing cells (Fig. 6 e-2) and Hoechst (Fig. 6 e-3) at 25 d
after transplantation. These results demonstrate that
MDSC differentiate into both endothelial and peripheral
nerve cells after implantation in mdx skeletal muscle. The
ability of the MDSC to differentiate into blood vessels
and neural lineages may contribute to the regeneration of
functional muscle tissue with adequate neurogenic and
vascular supplies.
Discussion
Three populations of muscle-derived cells, EP cells, LP cells,
and MDSC, were isolated in the present study according to
their adhesion characteristics and proliferation behaviors. EP
and LP cells represent two populations of satellite cells based
on their patterns of myogenic marker expression and their
behavior in vitro. However, the MDSC displayed unique
characteristics that are usually associated with noncommit-
ted progenitor cells. First, the detection of similar pheno-
types in MDSC, as well as in cloned and subcloned MDSC,
and the maintenance of the MDSC phenotype for a long pe-
riod of time in vitro (30 passages) indicate that the MDSC
are capable of self-renewal in vitro. Importantly, these highly
proliferating cells can be expanded in vitro for over 30 pas-
sages while preserving a normal karyotype and are incapable
of developing tumors in immunodeficient scid mice. Sec-
ond, the ability of the MDSC to replenish myogenic pro-
genitors (m-cadherin– and Sca-1–expressing donor-derived
cells) within the injected dystrophic muscle suggests that the
MDSC also are capable of self-renewal in vivo. Third, the
ability of the MDSC to highly proliferate in vitro and to
contribute to a persistent restoration of dystrophin
  myofi-
bers within the transplanted muscle, in which a large num-
ber of small regenerating myofibers can be observed for up
to 90 d after injection, demonstrates that the MDSC possess
a high capacity for long-term proliferation in vitro and in
vivo. Fourth, the detection of donor-derived cells in myofi-
Figure 6. Multipotent differentiation 
of MDSC in the injected skeletal 
muscle in vivo. 10 (a) and 25 d (b–e) 
after transplantation. (a-1–a-3) MDSC 
that were genetically engineered to 
express the lacZ reporter gene (nuclear 
localization) were injected into the m. 
gastrocnemius of mdx mice. At 10 d 
after injection, we detected many lacZ
  
cells in the transplanted muscle (a-1). In 
the injected area, a vessel-like structure 
containing lacZ
  nuclei was also found 
(a-2, arrowheads). Some peripheral 
nerve–like structures (a-3, arrowheads) 
with lacZ
  nuclei (a-3, arrow) were also 
found in the injected site. (b) At 25 d 
after transplantation, we observed some 
lacZ
  nuclei (b-1, arrow) in the 
endothelium of well-differentiated 
blood vessels (b-1, star), which was 
confirmed by vWF staining in adjacent 
sections (b-2, star). (c) LacZ
  nuclei 
(arrow) were also found in well-
differentiated peripheral nerves in the 
injected skeletal muscle at 25 d after 
transplantation. (d) Colocalization 
of  -galactosidase, vWF, and Hoechst 
by immunochemistry revealed 
 -galactosidase
  nuclei (d-1, green, 
arrowhead) in vWF
  structure (d-1, red) 
and costained with Hoechst (d-2 and 
d-3, arrowhead). (e) After transplantation 
of MDSC isolated from GFP transgenic 
mice, some peripheral nerve structures expressing CNPase immunoreactivity, a Schwann cell marker (e-1, red), were colocalized with 
GFP-expressing cells (e-2) and Hoechst (e-3) in the transplanted mdx TA muscle. Triple exposure of CNPase, GFP, and Hoechst (blue) is 
shown in e-3. Bars: (a-1) 500  m; (b, c, and e) 50  m; (d) 25  m. Identification of muscle stem cells in mice | Qu-Petersen et al. 859
bers, peripheral nerves, and blood vessels within the MDSC-
injected muscle provides evidence of the multipotent nature
of MDSC in vivo, as observed in vitro, when appropriately
stimulated with growth factors. Based on this evidence, the
MDSC were confirmed as a novel population of muscle
stem cells with the capacities for high self-renewal, long-
term proliferation, and multipotent differentiation.
Based on the relative number of cells isolated in the differ-
ent fractions of muscle-derived cells (EP, LP, and MDSC),
EP cells represent the main population of myogenic cells de-
rived from skeletal muscle. More than 90% of the EP cells
express the myogenic marker desmin and markers of the
later stages of myogenesis, such as m-cadherin and myoge-
nin (Miller et al., 1999), suggesting that EP cells represent a
late myogenic precursor. The EP cells exhibited a very fast
but limited ability to proliferate, as well as a strong capacity
to differentiate into myotubes. These EP cell characteristics
are similar to previous findings in satellite cells (Bischoff,
1986; Baroffio et al., 1996; Schultz, 1996). A main popula-
tion of m-cadherin
  satellite cells was also detected in nor-
mal muscle sections beneath the basement membrane, indi-
cating that the EP cells were derived from the common
satellite cell population. Surprisingly, although the trans-
planted EP cells were highly purified and 95% of them ex-
pressed desmin, they still displayed a limited capacity to re-
generate skeletal muscle after cell implantation. We believe
that the poor ability of the EP cells to proliferate and to self-
renew in the regenerating mdx muscles explained, at least in
part, their limited regeneration capabilities in vivo.
The LP population represents  1% of satellite cells, and
their function in skeletal muscle remains unclear because
they displayed a very limited capacity to proliferate and dif-
ferentiate. In a preliminary experiment, transplantation of
quiescent LP cells that were cultured for only 1–2 d did not
show the same efficiency of muscle regeneration at 30 d after
transplantation, when compared with the MDSC. This is
intriguing because the primitive MDSC were isolated from
the LP cultures (see Materials and methods). It is possible
that the primitive MDSC within LP cultures need specific
unknown conditions to be activated before they become ef-
fective in contributing to muscle regeneration. Therefore,
activation of primitive MDSC by appropriate growth factors
in LP cultures may play a major role in the activation pro-
cess and should be investigated in future experiments.
Difficulty was encountered when evaluating the relative
number of cells in the MDSC populations within the
muscle cell culture. Culturing LP cells at high confluence
(60–70% confluence) often resulted in large numbers of
differentiated cells with typical fibroblast morphology.
The fibroblast-like cells may come from either the LP
culture or from the differentiation of MDSC daughter
cells, which often grow faster than their parent cells.
When the LP cells were cultured at low confluence
( 30%), most of the LP cells died within 1–2 wk, and
only rare primary MDSC clones appeared. According to
our findings in muscle cultures prepared from newborn
mice, the ratio of the three populations of myogenic cells
is as follows: 10
5 relatively quiescent EP cells contained
10
2 relatively quiescent LP cells, in which one MDSC
clone could be obtained.
Additionally, it is difficult to investigate the source of
MDSC, considering their relatively low number in skeletal
muscle. Given recent studies in which pluripotent bone
marrow stem cells (Ferrari et al., 1998; Gussoni et al.,
1999), blood vessel progenitors (De Angelis et al., 1999),
neural stem cells (Clarke et al., 2000; Galli et al., 2000), and
mesenchymal stem cells isolated from interstitial connective
tissue (Young et al., 2001a,b) have all shown the capacity to
differentiate into muscle lineage, these MDSC can be de-
rived from various sources. We found that MDSC express
the hematopoietic stem cell markers CD34 and Sca-1, as
well as neural and endothelial markers (when appropriately
stimulated). Various features suggest, however, that the
MDSC derived from skeletal myofibers. These features in-
clude (a) the potential of MDSC to differentiate into skeletal
muscle lineage both in vitro and in vivo, a potential which is
even higher than that of satellite cells; (b) their ability to
spontaneously express myogenic markers, such as desmin
and MyoD, without the requirement of myogenic stimula-
tion; and (c) their similarity in phenotype to a subpopula-
tion of cells that has been identified within the basal lamina
of myofibers, i.e., Sca-1
 /m-cadherin
  (Fig. 1, g–l), as well
as CD34
  and Bcl2
  (Lee et al., 2000).
Although  95% of cells in expanded MDSC cultures ex-
pressed desmin, an early stage myogenic marker, only 30–
40% of MDSC at earlier passages (10–12 passages) were
found to be desmin
 . It is reasonable to speculate that the
primitive MDSC do not express desmin. Therefore, the pri-
mary MDSC may be characterized phenotypically by myo-
genic lineage
 , CD34
   , and Sca-1
 . In the transplantation
experiment, long-term engraftments were observed in the
muscle injected with the MDSC (myogenic lineage
 / ,
CD34
 / , Sca-1
 ), but not in the muscle injected with the
EP cells (myogenic lineage
 , CD34
 , Sca-1
 / ). In contrast
to the EP culture, a small population (10%) of MDSC is
Sca-1
 /CD34
 . It is very interesting that murine hemato-
poietic stem cells with long-term reconstituting capability
are found to be in the hematopoietic lineage
 , CD34
low/ ,
Sca-1
  populations (Osawa et al., 1996; Sato et al., 1999). It
is possible that different organ-specific stem cells may share
some similarities in terms of surface antigen expression. The
identification of surface antigens specific to muscle stem
cells will help to enhance the rapid isolation of this minority
of long-time proliferating stem cells from muscle, as this
would result in a more efficient isolation technique. Indeed,
we recently demonstrated that the use of magnetic cell sort-
ing to rapidly isolate and transplant phenotypically pure
Sca-1
  myogenic cells (CD45
 ) resulted in the regeneration
of skeletal muscle and restoration of dystrophin expression
in host mdx mice (Jankowski et al., 2001).
An important point of the current investigation is the dem-
onstration of the functional ability of this specific population
of MDSC to regenerate dystrophic muscle (mdx) after trans-
plantation. Transplantation of normal muscle precursors for
treatment of inherited myopathies, such as Duchenne muscu-
lar dystrophy, has been widely studied (Partridge et al., 1989;
Partridge, 1991; Morgan et al., 1990, 1993, 1994; Miller et
al., 1997; Qu and Huard, 2000). The results from animal and
human clinical trials have suggested that although myoblast
transplantation is feasible (Partridge, 1991; Morgan et al., 1993;860 The Journal of Cell Biology | Volume 157, Number 5, 2002
Miller et al., 1997), it is rather inefficient (Huard et al.,
1992a,b; Karpati et al., 1992; Tremblay et al., 1993; Mendell
et al., 1995; Miller et al., 1997). The low survival rate, poor
spreading of transplanted cells, and immunorejection of the
donor cells are still major problems facing myoblast transplan-
tation (Huard et al., 1994a,b; Fan et al., 1996; Guerette et al.,
1997; Beauchamp et al., 1999; Hodgetts et al., 2000; Skuk et
al., 2000; Smythe et al., 2000). In animal experiments, im-
munodeficient animals and/or immune-suppressive regimens
(Huard et al., 1992a, 1994a; Morgan et al., 1993, 1994; Ki-
noshita et al., 1994; Pavlath et al., 1994), preirradiation of the
injected muscle (Morgan et al., 1993), and myonecrotic
agents (Huard et al., 1994a; Vilquin et al., 1995) have been
used extensively to improve the success of this technique. Al-
though these approaches may be used to improve the restora-
tion of dystrophin in mdx mice, the success of this technique
remains rather limited and largely clinically impractical.
In the present study, the cell transplantation was successful
from 10 to 90 d after injection of the MDSC into mdx muscle.
The number of dystrophin
  myofibers observed at 10 d after
injection (2,178 myofibers) was not significantly different
from the number of dystrophin
  myofibers observed at 90 d
(1,851 myofibers) after transplantation. Interestingly, the mdx
mice used as recipients in this experiment were not immuno-
suppressed, and the injected muscles were not preirradiated or
injured with a myonecrotic agent. The injection of MDSC re-
sulted in 10 times more dystrophin
  myofibers in the injected
muscle than did the transplantation of EP cells (1,435 vs. 136
fibers) by 30 d after transplantation, although the same num-
ber of cells (3–4   10
5) was injected in both groups. These re-
sults illustrate that the MDSC display an improved transplan-
tation capacity in skeletal muscle when compared with the EP
cells. Therefore, we have attempted to elucidate the mecha-
nism by which the MDSC display improved transplantation
capacity by characterizing their self-renewal ability, along with
their immune-privileged behavior and their multipotent differ-
entiation, after implantation in skeletal muscle.
Unlike the MDSC, the transplanted EP cells exhibited a
dramatic decrease in the number of dystrophin
  myofibers
from day 10 to day 30. In view of the previous report that
dystrophin is antigenic in dystrophin-deficient mice (Oht-
suka et al., 1998) and also the reports in which serum anti-
body formation has been found to be triggered by donor
myoblasts (Huard et al., 1992a; Tremblay et al., 1993;
Vilquin et al., 1995), we have investigated the immune re-
jection against the injected cells. Detection of CD4 and
CD8 T lymphocytes in all EP-injected muscles at 10 and
30 d after injection provides evidence to support the im-
mune rejection of the EP cells. Surprisingly, an absence of
infiltration with CD4 or CD8 T-lymphocytes was ob-
served in many of the MDSC-injected muscles at 30 and
90 d after transplantation, despite the large numbers of
dystrophin
  myofibers found in the injected muscles.
These results suggest that MDSC are less immunogenic
than EP cells. The lack of expression of MHC-1 by the
MDSC further supports this contention. These latter re-
sults suggest that the improved transplantation capacity of
MDSC may be attributed to their inability to trigger an in-
filtration of activated lymphocytes, which would partici-
pate in the immune rejection of the transplanted cells.
We also have observed that the MDSC can self-renew both
in vitro and in the injected skeletal muscle in vivo. Indeed,
MDSC can be expanded in vitro for up to 30 passages while
maintaining their phenotype in terms of both myogenic and
stem cell marker expression profiles. In addition, subclones of
MDSC display a phenotype almost identical to the MDSC
clone from which they were derived; this fact provides evi-
dence of the in vitro self-renewing capability of these cells. Fi-
nally, five times more lacZ
  cells were detected in the muscle
cultures derived from MDSC-injected muscle, when com-
pared with the EP cell–injected muscle. Moreover, the detec-
tion of Sca-1
  and m-cadherin
  cells in MDSC-injected mus-
cle suggests that MDSC give rise to myogenic precursor cells
more effectively than do EP cells. The high self-renewal ability
displayed by MDSC both in vitro and in vivo may also con-
tribute to the persistent dystrophin delivery into mdx mice.
We also investigated whether the injected cells can differen-
tiate into blood vessels and nerve cells with the potential to
contribute to the regeneration of functional muscle tissue with
adequate vascular and nerve supplies. Indeed, our in vitro re-
sults suggest that the stimulation of the MDSC with NGF
and VEGF increased the number of CNPase- and vWF-
expressing cells, respectively. More importantly, in the in vivo
experiments, although the MDSC were not stimulated or
transduced with NGF and VEGF, the injected cells could still
differentiate into endothelial and peripheral nerve lineages.
Based on these results, we believe that the release of environ-
mental stimuli (e.g., growth factors) within the dystrophic
muscle triggers the differentiation of the MDSC toward other
lineages. Such results suggest that multipotent differentiation
of MDSC may contribute to the regeneration of functional
muscle tissue in transplanted mdx mice. The ability of the
MDSC to restore the function of the dystrophic mdx muscle
is important and will be investigated further. It was also found
that primary MDSC (passage 10) showed much higher poten-
tial than later passages (after 30 passages) to differentiate into
muscle and other lineages. In extended cultures (after 40 pas-
sages), some of the MDSC gradually lost their ability to re-
generate muscle fibers or differentiate into other lineages, sug-
gesting that the mechanism that governs the differentiation of
multipotent muscle stem cells toward a specific lineage is yet
to be determined. Further investigation of the gene expression
program, as well as the proper culture condition by which the
proliferation and differentiation of multipotent stem cells
could be controlled, is paramount for the development of
muscle stem cell transplantation for Duchenne muscular dys-
trophy patients.
In summary, three populations of myogenic cells have
been isolated by a modified version of the preplate tech-
nique. The EP and LP cells are derived from the main popu-
lation of satellite cells and are a type of committed muscle
precursor. The MDSC, derived from the subpopulation of
LP cells, are characterized by myogenic lineage
 / , CD34
 / ,
Sca-1
 , c-Kit
 , and CD45
 . The use of MDSC can cir-
cumvent hurdles facing myoblast transfer therapy and, con-
sequently, improve the efficiency of muscle regeneration and
dystrophin delivery to dystrophic muscle. The unique
features of the MDSC, including (a) their long-time prolif-
erating ability, (b) their strong self-renewal, (c) their mul-
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havior after implantation, at least partially elucidate the basis
of the improved transplantation capacity of this novel popu-
lation of MDSC.
Materials and methods
Animals
Normal mice (C57 BL/6J) and mdx mice (C57BL/10ScSn DMD
mdx/J) used
in this experiment were purchased from Jackson ImmunoResearch Labo-
ratories. All animal protocols used for these experiments were approved
by the Children’s Hospital of Pittsburgh’s IACUC committee (protocol
nos. 2/00 and 7/00).
Preparation of different populations of muscle-derived cell cultures
Primary muscle cultures were prepared from newborn (3–5 d) normal
mice, and the MDSC were purified from the primary culture using a
modified version of a previously described preplate technique (Richler
and Yaffe, 1970; Rando and Blau, 1994; Qu et al., 1998; Qu and Huard,
2000). The hindlimb muscles of neonatal mice were removed, and the
bones were dissected. The muscle was then minced into a coarse slurry
using scalpels. The muscle tissue was enzymatically dissociated at 37 C
in 0.2% collagenase-type XI (Sigma-Aldrich) for 1 h, and then centri-
fuged at 3,500 rpm for 5 min. The cells were collected, incubated in dis-
pase (GIBCO BRL), prepared as 2.4 units/1 ml HBSS (GIBCO BRL), for 45
min, and then incubated for 30 min in 0.1% trypsin-EDTA (GIBCO BRL)
diluted in HBSS. After the enzymatic dissociation, the muscle cells were
centrifuged and resuspended in proliferation medium (PM). PM consists
of DME containing 10% horse serum, 10% FBS, 0.5% chick embryo ex-
tract, and 1% penicillin–streptomycin (all reagents purchased from
GIBCO BRL). Different populations of muscle-derived cells were isolated
based on their adhesion characteristics. A flow chart for the isolation of
muscle-derived cells (EP, LP, and MDSC) is shown in Fig. 7. The muscle
cells were plated on collagen-coated flasks (collagen type 1; Sigma-
Aldrich) for 2 h (preplate 1 [pp1]). The nonadherent cells were then
transferred to other flasks (pp2), and the adherent cells in pp1 were dis-
carded. It has been reported that the cells that rapidly attach are highly fi-
broblastic in nature (Richler and Yaffe, 1970; Rando and Blau, 1994; Qu
et al., 1998; Qu and Huard, 2000). After 24 h, the floating cells in pp2 were
collected, centrifuged, and plated on new flasks (pp3). These procedures
were repeated at 24-h intervals until serial preplates (pp4–6) were ob-
tained. All cell populations (pp2–6) were maintained in PM with daily
changes. Based on the previous report (Qu et al., 1998), 30–40% of the
cells in pp2 and pp3 are known to be nonmyogenic, whereas up to 95%
desmin
  cells can be found in pp4 and pp5. To further purify the
desmin
  cells within pp2 and pp3, the cells were subsequently tryp-
sinized and replated in fresh collagen-coated flasks using a previously
described protocol (Qu and Huard, 2000). After 30 min, the supernatant
containing mostly nonadherent cells ( 90% of which were shown to be
desmin-expressing cells) were plated in new flasks. These nonadherent
cells from pp2 and pp3 were combined with the cells from pp4 and pp5
and used in the transplantation experiment as the EP population. To iso-
late MDSC, pp6 cells (also termed LP cells) were plated in collagen-
coated 12-well dishes at 50–100 cells/well (Fig. 7). Though most of the
LP cells died within 1–2 wk of culturing, the MDSC formed clonal colo-
nies during the first 2 wk of culturing. The MDSC take 5–7 d to attach to
collagen-coated flasks, and require  1–2 wk to develop clones, from 1
to  300–500 cells. The doubling time of these cells is  24–36 h at the
early stage of culturing, which means that these cells divided eight to
nine times in the first 2 wk of culturing. The wells containing multiple
MDSC colonies were trypsinized (0.25% trypsin) and the detached cells
were transferred into a collagen-coated 6-well dish. The MDSC were
then grown in PM to  30% confluence and subsequently passaged. The
well containing a single colony was selected and these cells were called
MDSC clones. These MDSC clones were expanded and used to isolate
subclones via a protocol previously described (Lee et al., 2000). The
MDSC cloned and subcloned cells were also expanded in PM as de-
scribed above. We have also isolated MDSC, by using the same tech-
nique as described above, from the skeletal muscle of GFP transgenic
mice (C57BL/6-TgN[ACTbEGFP]) (Okabe et al., 1997).
Cell cycle duration
The EP cells and MDSC were plated in 24-well collagen-coated plates at
a density of 450 cells/well in PM. Using the CytoWorks platform, visible
imaging was obtained for individual cells. This system uses a biobox in-
cubator mounted to the stage of a Nikon microscope, which is linked to
a CCD camera (Automated Cell Technologies, Inc.). Stage movement
was computer controlled, allowing for images of each view field to be
acquired at 10-min intervals for 5 d. For each population, 100 cells
were selected and tracked. The division time of each cell was deter-
mined by direct observation of the cells through the CytoWorks plat-
form as previously described (Deasy et al., 2002). The initiation of cell
division was marked at the time when two daughter cells were formed,
and these cells were subsequently followed until their respective divi-
sion. The lapsed time between those two division events was recorded
as the length of the cell division cycle.
Figure 7. Isolation of three populations 
of muscle-derived cells. Muscle-derived 
cells were enzymatically dissociated 
from neonatal mouse skeletal muscle 
and separated by their adhesion 
characteristics to collagen-coated flasks 
(modified preplate technique). After the 
enzymatic dissociation, the muscle cell 
extract was resuspended in PM and 
preplated on collagen-coated flasks. 
Different populations of muscle-derived 
cells were isolated based on adhesion 
characteristics. pp1 represented a 
population of primary fibroblasts that 
adhered in the first 2 h after isolation; 
subsequent preplates, containing a 
mixture of myogenic and nonmyogenic 
cells, were obtained at 24-h intervals 
(pp2–6). The nonmyogenic cells in pp2 
and pp3 were removed from the cultures 
by replating the cells, and the resulting 
enriched pp2 and pp3 desmin
  cells 
were combined with pp4 and pp5 cells 
and were termed the EP population. 
Cells in the pp6 cell population took an 
additional 24–72 h to attach to collagen-coated dishes after transfer from pp5 and were termed LP cells. Most of the LP cells died during the 
first 1–2 wk of the cultivation period, with very few of the adherent surviving cells proliferating and forming clonal colonies. The surviving 
clones are called MDSC. We also isolated subclones from a single clone of MDSC, as shown in the flow chart.862 The Journal of Cell Biology | Volume 157, Number 5, 2002
Immunocytochemistry on cultures
The primary antibodies used in this study were mouse anti-desmin (1:200;
D-1033; Sigma-Aldrich), rabbit anti–mouse m-cadherin (1:50; obtained
from A. Wernig), rabbit anti–mouse Bcl2 (1:1,000; 15616E; BD PharMin-
gen), biotin anti–Sca-1 (1:200; BD PharMingen), biotin anti–mouse CD34
(1:200; 09432D; BD PharMingen), mouse anti-myogenin (1:100; 65121A;
BD PharMingen), and mouse anti-MyoD (1:200; 13941A; BD PharMin-
gen). EP cell, LP cell, and MDSC (cloned and subcloned) cultures were
fixed and stained as previously described (Lee et al., 2000).
RNA analyses
RT-PCR analyses of EP and MDSC cultures were performed as previously de-
scribed (Lee et al., 2000). Total RNA was isolated using TRIzol reagent (Life
Technologies). Reverse transcription was performed using SuperScript
TM First-
Strand Synthesis System (Life Technologies) according to the manufacturer’s
instructions. PCR primer sequences and reaction parameters are from refer-
ences as follows: Bcl2 (Dominov et al., 1998); CD34 (Lee et al., 2000); myo-
genin and MyoD (Rohwedel et al., 1995); and MNF (Yang et al., 1997). PCR
product sizes were analyzed on agarose gel. The expected product sizes were
Bcl-2, 480 bp; CD34, 147 bp; myogenin, 86 bp; MyoD, 147 bp; and MNF,
305 bp. Genomic DNA contamination was excluded by (a) primers spanning
an intron and (b) reverse transcription reactions without reverse transcriptase.
Flow cytometry
The percentages of CD34
  and Sca-1
  cells in the MDSC and EP cultures
were analyzed by flow cytometry as recently described (Jankowski et al.,
2001). Cultured cells were trypsinized, spun, washed in cold PBS (Dulbecco
phosphate-buffered salt solution 1 ; Mediatech) containing 0.5% BSA (ICN
Biomedicals), and counted. The cells were then divided into equal aliquots
and spun to a pellet. A 1:10 mouse serum (Sigma-Aldrich) in PBS solution
and Fc Block (rat anti–mouse CD16/CD32; BD PharMingen) was used to re-
suspend each pellet, and the suspensions were incubated for 10 min on ice.
Optimal amounts of both direct and biotin-conjugated rat anti–mouse mono-
clonal antibodies (c-kit, CD34, Sca-1, and CD45; all from BD PharMingen)
were predetermined and added directly to each tube for 30 min. A similar
protocol was used to separately analyze MDSC and EP cells for MHC-1 ex-
pression using a biotin-conjugated H-2k
b antibody (BD PharMingen).
Streptavidin–allophycocyanin conjugate was added to tubes containing
cells labeled with biotinylated antibodies for 20 min. Just before analysis,
7-amino-actinomycin D (Via-Probe; BD PharMingen) was added to each tube
for dead cell exclusion. Live cell events were collected and analyzed on a
FACSCalibur
® (Becton Dickinson) flow cytometer using Cell Quest software.
Stimulation of MDSC with growth factors
MDSC and two subclones of the MDSC clones (msc1 and msc3) were
stimulated with NGF (10 ng/ml; Sigma-Aldrich) or VEGF (15 and 25 ng/ml;
Sigma-Aldrich) for 5 d. Cells were plated at 20–30% confluence on col-
lagen-coated flasks. PM containing growth factors was added to the wells,
and PM without NGF and VEGF was added to the control wells. Immuno-
cytochemistry was performed to examine the expression of CNPase and
vWF. For the CNPase immunostaining, the primary antibody used was a
mouse anti-CNPase (1:400; Sigma-Aldrich), and the secondary antibody
was an anti-mouse conjugated to Cy3 (1:200; Sigma-Aldrich). For vWF im-
munostaining, the primary antibody was a rabbit anti-vWF (1:400; Dako),
and the secondary antibody was an anti–rabbit-conjugated Cy3 (1:200;
Sigma-Aldrich). Desmin expression was also monitored in both the treated
and untreated wells using the protocol described above.
Cell transplantation
MDSC and EP cells were transplanted as previously described (Qu et al.,
1998; Qu and Huard, 2000). In brief, 3–4   10
5 viable cells suspended in
20  l of HBSS were transplanted (single-point injection) in the gastrocne-
mius muscle of mdx mice (C57BL/10ScSn DMD
mdx/J). The mdx mice used
as recipients in this experiment were not immunosuppressed, and the in-
jected muscles were not preirradiated or injured with a myonecrotic agent
before transplantation. EP cells were cultivated for only 5 d after the initial
seeding, whereas the MDSC were at passages 10–12 at the time of trans-
plantation. The animals were killed at 10, 30, and 90 d after injection. The
injected muscles were isolated and then frozen in 2-methylbutane pre-
cooled in liquid nitrogen.
EP and MDSC cultures also were transduced with a retrovirus carrying
the gene encoding for  -galactosidase (nuclear localization) for 24 h be-
fore transplantation, using a protocol previously described (Lee et al.,
2000). We injected 5   10
5 cells into each gastrocnemius muscle. By 30 d
after injection, the animals were killed; some of the injected muscles
were frozen, sectioned, and stained for lacZ expression (histochemistry),
whereas others were used to prepare muscle cell cultures using a protocol
similar to that described above (Fig. 7). The GFP-expressing MDSC (1  
10
5 cells for each population) were injected into the tibialis anterior (TA)
muscles of mdx mice (9 wk old). By 25 d after injection, the animals were
killed; TA muscles were fixed with 1% paraformaldehyde, frozen, and sec-
tioned for immunohistochemistry.
Immunohistochemical staining of muscle sections: normal muscle
Normal muscle samples were obtained from 4-wk-old mice and frozen in
2-methylbutane precooled with liquid nitrogen. Serial cryosections of 10
 m in thickness were prepared from the frozen muscles. The sections were
fixed with cold acetone ( 20 C) for 2 min, preincubated in 5% horse se-
rum diluted with PBS for 30 min, and then rinsed thoroughly with PBS. The
following is a list of stainings performed on these muscle sections. Control
stainings without primary and secondary antibodies were also performed.
Colocalization of Sca-1 and laminin.  The sections were incubated with a
biotin anti–mouse Sca-1 antibody (1:200 dilution) for 2 h and streptavidin-
conjugated Cy3 (1:200) for 90 min. The sections were then incubated with
rabbit anti–mouse laminin (1:100) for 1 h and anti–rabbit IgG-conjugated
fluorescein for 1 h (1:100). The nuclei were revealed by Hoechst 33342
staining.
Colocalization of Sca-1, m-cadherin, and laminin.  After preincubation,
the sections were incubated with PE-conjugated anti–mouse Sca-1 (1:150;
BD PharMingen) for 2 h, rabbit anti–m-cadherin (1:50) for 3 h, biotinylated
anti–rabbit IgG (1:100; Vector Laboratories) for 90 min, and FluoroLink
TM
Cy
TM5–labeled streptavidin (1:1,000, Amersham Pharmacia Biotech) for 90
min, respectively. The sections were then incubated with rabbit anti–mouse
laminin (1:100) for 30 min and anti–rabbit IgG-conjugated fluorescein
(1:200) for 30 min. The nuclei were revealed by Hoechst 33342 staining.
Immunohistochemical staining of muscle sections: transplanted 
mdx muscle
Dystrophin staining.  The staining was performed on muscle sections as
previously described (Qu and Huard, 2000), and the sections were coun-
terstained with Hoechst to visualize the locations of the nuclei.
Colocalization of m-cadherin and dystrophin.  The sections were incu-
bated with a rabbit anti–m-cadherin antibody (1:50) for 2 h and anti–rabbit
IgG-conjugated fluorescein for 90 min. The sections were then stained for
dystrophin and counterstained with Hoechst using the same protocol de-
scribed above.
CD4 and CD8 staining.  Sections were incubated with rat anti–mouse
CD4 or CD8 (1:400; BD PharMingen) for 2 h and then with biotinylated
anti–rat IgG (1:200; Vector Laboratories) and streptavidin-conjugated Cy3
(1:200; Sigma-Aldrich) for 90 min. The number of CD4 and CD8 lympho-
cytes was also monitored and compared between the EP- and MDSC-
injected muscles (n   4). Some of the sections were also stained for dystro-
phin (see “Dystrophin staining” above).
vWF/ -galactosidase staining.  Muscle sections were incubated with
mouse anti– -galactosidase (1:100; Chemicon), and the next steps were
performed in accordance with the instructions of the MOM kit manufac-
turers (FMK-2201; Vector Laboratories). The sections were then incubated
with rabbit anti-vWF (1:400; Dako) followed by a 1-h incubation with an
anti–rabbit IgG-conjugated fluorescein (1:100). Finally, the sections were
stained with Hoechst as described above.
CNPase staining.  The TA muscle sections (injected with GFP-expressing
MDSC) were incubated with mouse anti-CNPase (1:400; Sigma-Aldrich),
and the next steps were performed in accordance with the MOM kit man-
ufacturer’s instructions, except for using streptavidin-conjugated Cy3 to re-
place fluorescein-conjugated avidin. The sections were consequently
stained with Hoechst as described above.
Histochemistry
LacZ staining for culture.  The muscle cells isolated from the EP- and
MDSC-injected muscles were fixed in 1% glutaraldehyde and incubated
overnight with X-gal substrate at 37 C.
LacZ staining for muscle sections.  The sections were fixed in 1% glu-
taraldehyde, incubated overnight with X-gal substrate at 37 C, and then
counterstained with eosin (Sanes et al., 1986).
Karyotype analysis of MDSC
Cytogenetic analysis of the MDSC was performed using a technique previ-
ously described (Barch, 1991; Lee et al., 2000). Cells were grown to
 40% confluency in a T75 collagenated flask in DME (GIBCO BRL) sup-
plemented with 10% horse serum (GIBCO BRL), 10% FBS (GIBCO BRL),
0.5% chick embryo extract (GIBCO BRL), and 1% Pen-Strep solution
(GIBCO BRL). Colcemid solution (GIBCO BRL) was added to the flask at a Identification of muscle stem cells in mice | Qu-Petersen et al. 863
final concentration of 0.05  g/ml and allowed to incubate for 3 h at 37 C.
Cells were then harvested by adding 0.1% trypsin-EDTA to the cells until
they lifted. Cells were spun down (3,200 rpm, 5 min), resuspended in 5 ml
0.75 M KCl, and incubated for 10 min at 37 C. Next, 3 ml of Carnoy’s fix-
ative (3:1 methanol to glacial acetic acid) was added to the solution,
which was vigorously pipetted. The cells were then pelleted as before.
Fresh fixative was added and cells were again pelleted. This rinsing and
pelleting was performed three additional times. Cells were then dropped
on glass slides and allowed to dry overnight at 55 C. Metaphase cells were
GTG banded following a protocol outlined by Invitrogen. 28 metaphase
cells were then counted for modal number using a magnification of 630 .
Images for karyotype analysis were captured using AKS software (Image-
netics, Inc.).
Statistical analysis
The data in this manuscript are presented as means   SD. Means were
compared using an unpaired t test for the number of dystrophin
  myofibers
between EP cell– and MDSC-transplanted groups. A paired t test was used
to compare the numbers of centronucleated myofibers, m-cadherin
  cells,
and Sca-1
  cells between injected and noninjected areas in transplanted
mdx muscle.
The authors thank Marcelle Pellerin for her technical assistance, and Lau-
ren Rudick, Melissa Haas, and Ryan Sauder for their assistance with the
manuscript. The authors also wish to thank Dr. Paul D. Robbins (Univer-
sity of Pittsburg) for the retroviral vector, Dr. Joel Greenberger (University
of Pittsburgh) for assistance with the combinatorial cell culture system to
measure cell division time, and Dr. Lou Kunkel (Children’s Hospital, Bos-
ton, MA) for the 6-10 dystrophin antibody. 
This work was supported by grants to Dr. Johnny Huard from the Mus-
cular Dystrophy Association, the Parent Project (USA), the National Insti-
tutes of Health (NIH 1P01 AR45925-01), and the William F. and Jean W.
Donaldson Chair at Children’s Hospital of Pittsburgh.
Submitted: 30 August 2001
Revised: 25 March 2002
Accepted: 2 April 2002
References
Baroffio, A., M. Hamann, L. Bernheim, M.L. Bochaton-Piallat, G. Gabbiani, and
C.R. Bader. 1996. Identification of self-renewing myoblasts in the progeny
of single human muscle satellite cells. Differentiation. 60:47–57.
Barch, M.J. 1991. Chromosome analysis. In The ACT Cytogenetics Laboratory
Manual. 2nd ed. Raven Press, Ltd., New York. 349.
Beauchamp, J.R., J.E. Morgan, C.N. Pagel, and T.A. Partridge. 1999. Dynamics of
myoblast transplantation reveal a discrete minority of precursors with stem
cell–like properties as the myogenic source. J. Cell Biol. 144:1113–1122.
Beauchamp, J.R., L. Heslop, D.S. Yu, S. Tajbakhsh, R.G. Kelly, A. Wernig, M.E.
Buckingham, T.A. Partridge, and P.S. Zammit. 2000. Expression of CD34
and Myf5 defines the majority of quiescent adult skeletal muscle satellite
cells. J. Cell Biol. 151:1221–1234.
Bischoff, R. 1986. Proliferation of muscle satellite cells on intact myofibers in cul-
ture. Dev. Biol. 115:129–139.
Clarke, D.L., C.B. Johansson, J. Wilbertz, B. Veress, E. Nilsson, H. Karlstrom, U.
Lendahl, and J. Frisen. 2000. Generalized potential of adult neural stem
cells. Science. 288:1660–1663.
De Angelis, L., L. Berghella, M. Coletta, L. Lattanzi, M. Zanchi, M.G. Cusella-De
Angelis, C. Ponzetto, and G. Cossu. 1999. Skeletal myogenic progenitors
originating from embryonic dorsal aorta co-express endothelial and myo-
genic markers and contribute to postnatal muscle growth and regeneration.
J. Cell Biol. 147:869–878.
Deasy, B.M., Z. Qu-Petersen, J.S. Greenberger, and J. Huard. 2002. Mechanisms
of muscle stem cell expansion with cytokines. Stem Cells. 20:50–60.
Dominov, J.A., J.J. Dunn, and J.B. Miller. 1998. Bcl2 expression identified an
early stage of myogenesis and promotes clonal expression of muscle cells. J.
Cell Biol. 142:537–544.
Emslie-Smith, A.M., K. Arahata, and A.G. Engel. 1989. Major histocompatibility com-
plex class I antigen expression, immunolocalization of interferon subtypes, and T
cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20:224–231.
Fan, Y., M. Maley, M. Beilharz, and M. Grounds. 1996. Rapid death of injected
myoblasts in myoblast transfer therapy. Muscle Nerve. 19:853–860.
Fennie, C., J. Cheng, D. Dowbenko, P. Young, and L.A. Lasky. 1995. CD34  en-
dothelial cell lines derived from murine yolk sac induce the proliferation and
differentiation of yolk sac CD34  hematopoietic progenitors. Blood. 86:
4454–4467.
Ferrari, G., G. Cusella-De Angelis, M. Coletta, E. Paolucci, A. Stornaiuolo, G.
Cossu, and F. Mavilio. 1998. Muscle regeneration by bone marrow-derived
myogenic progenitors. Science. 279:1528–1530.
Galli, R., U. Borello, A. Gritti, M.G. Minasi, C. Bjornson, M. Coletta, M. Mora, M.G.
De Angelis, R. Fiocco, G. Cossu, and A.L. Vescovi. 2000. Skeletal myogenic po-
tential of human and mouse neural stem cells. Nat. Neurosci. 3:986–991.
Guerette, B., I. Asselin, D. Skuk, M. Entman, and J.P. Tremblay. 1997. Control of
inflammatory damage by anti-LFA-1: increase success of myoblast transplan-
tation. Cell Transplant. 6:101–107.
Gussoni, E., H.M. Blau, and L.M. Kunkel. 1997. The fate of individual myoblasts
after transplantation into muscle of DMD patients. Nat. Med. 3:970–977.
Gussoni, E., Y. Soneoka, C.D. Strickland, E.A. Buzney, M.K. Khan, A.F. Flint,
L.M. Kunkel, and R.C. Mulligan. 1999. Dystrophin expression in the mdx
mouse restored by stem cell transplantation. Nature. 401:390–394.
Hall, B.M., G.A. Bishop, G.G. Duggin, J.S. Horvath, J. Philips, and D.J. Tiller.
1984. Increased expression of HLA-DR antigens on renal tubular cells in re-
nal transplants: relevance to the rejection response. Lancet. 2:247–251.
Huard, J., R. Roy, J.P. Bouchard, F. Malouin, C.L. Richards, and J.P. Tremblay.
1992a. Human myoblast transplantation between immunohistocompatible
donors and recipients produces immune reactions. Transplant. Proc. 24:
3049–3051.
Huard, J., J.P. Bouchard, R. Roy, F. Malouin, G. Dansereau, C. Labrecque, N. Albert,
C.L. Richards, B. Lemieux, and J.P. Tremblay. 1992b. Human myoblast trans-
plantation: preliminary results of four cases. Muscle Nerve. 15:550–560.
Huard, J., A. Verreault, R. Roy, M. Tremblay, and J.P. Tremblay. 1994a. High ef-
ficiency of muscle regeneration following human myoblast clone transplan-
tation in SCID mice. J. Clin. Invest. 93:586–599.
Huard, J., G. Acsadi, B. Massie, and G. Karpati. 1994b. Gene transfer to skeletal
muscles by isogenic myoblasts. Hum. Gene Ther. 5:949–958.
Hodgetts, S.I., M.W. Beilharz, A.A. Scalzo, and M.D. Grounds. 2000. Why do
cultured transplanted myoblasts die in vivo? DNA quantification shows en-
hanced survival of donor male myoblasts in host mice depleted of CD4 
and CD8  cells or Nk1.1  cells. Cell Transplant. 9:489–502.
Jackson, K.A., T. Mi, and M.A. Goodell. 1999. Hematopoietic potential of stem
cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA. 96:
14482–14486.
Jankowski, R.J., C. Haluszczak, M. Trucco, and J. Huard. 2001. Flow cytometric
characterization of myogenic cell populations obtained via the preplate tech-
nique: potential for muscle-derived stem cells-mediated therapies. Hum.
Gene Ther. 12:619–628.
Karpati, G., P. Holland, and R.G. Worton. 1992. Myoblast transfer in DMD:
problems and interpretation of efficiency. Muscle Nerve. 15:1209–1210.
Kinoshita, I., J.T. Vilquin, B. Guerette, I. Asselin, R. Roy, and J.P. Tremblay.
1994. Very efficient myoblast transplantation in mice under FK 506 immu-
nosuppression. Muscle Nerve. 17:1407–1415.
Krause, D.S., T. Ito, M.J. Fackler, O.M. Smith, M.I. Collector, S.J. Sharkis, and
W.S. May. 1994. Characterization of murine CD34, a marker for hemato-
poietic progenitor and stem cells. Blood. 84:691–701.
Lee, J.Y., Z. Qu-Petersen, B. Cao, S. Kimura, R. Jankowski, J. Cummins, A. Usas,
C. Gates, P. Robbins, A. Wernig, and J. Huard. 2000. Clonal isolation of
muscle-derived cells capable of enhancing muscle regeneration and bone
healing. J. Cell Biol. 150:1085–1100.
Mason, D.W., and P.J. Morris. 1986. Effector mechanisms in allograft rejection.
Annu. Rev. Immunol. 4:119–145.
Mendell, J.R., J.T. Kissel, A.A. Amato, W. King, L. Signore, T.W. Prior, Z. Sa-
henk, S. Benson, P.E. McAndrew, and R. Rice. 1995. Myoblast transfer in
the treatment of Duchenne’s muscular dystrophy. N. Engl. J. Med. 333:
832–838.
Miller, J.B., L. Schaefer, and J.A. Dominor. 1999. Seeking muscle stem cells. Curr.
Top. Dev. Biol. 43:191–219.
Miller, R.G., K.R. Sharma, G.K. Pavlath, E. Gussoni, M. Mynhier, A.M. Lanctot,
C.M. Greco, L. Steinman, and H.M. Blau. 1997. Myoblast implantation in
Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve. 20:
469–478.
Milton, A.D., and J.W. Fabre. 1985. Massive induction of donor-type class I and
class II major histocompatibility complex antigens in rejecting cardiac al-
lografts in the rat. J. Exp. Med. 161:98–112.
Molnar, G., M.L. Ho, and N.A. Schroedl. 1996. Evidence for multiple satellite cell
populations and a non-myogenic cell type that regulated differently in regen-864 The Journal of Cell Biology | Volume 157, Number 5, 2002
erating and growing skeletal muscle. Tissue Cell. 28:547–556.
Morel, F., S.J. Szivassy, M. Travis, B. Chen, and A. Galy. 1996. Primitive hemato-
poietic cells in murine bone marrow express the CD34 antigen. Blood. 88:
3774–3784.
Morgan, J.E., E.P. Hoffman, and T.A. Partridge. 1990. Normal myogenic cells
from newborn mice restore normal histology to degenerating muscle of mdx
mouse. J. Cell Biol. 111:2437–2449.
Morgan, J.E., C.N. Pagel, T. Sherrat, and T.A. Partridge. 1993. Long-term persis-
tence and migration of myogenic cells injected into pre-irradiated muscle of
mdx mice. J. Neurol. Sci. 115:191–200.
Morgan, J.E., J.R. Beauchamp, C.N. Pagel, M. Peckham, P. Ataliotis, P.S. Jat,
M.D. Noble, K. Farmer, and T.A. Partridge. 1994. Myogenic cell lines de-
rived from transgenic mice carrying a thermolabile T antigen: a model sys-
tem for the derivation of tissue-specific and mutation-specific cell lines. Dev.
Biol. 162:486–498.
Mukai, K., J. Rosai, and W.H.C. Burgdirf. 1980. Localization of factor VIII-
related antigen in vascular endothelial cells using immunoperoxidase
method. Am. J. Surg. Pathol. 4:273–276.
Nakauchi, H., H. Takano, H. Ema, and M. Osawa. 1999. Further characterization
of CD34-low/negative mouse hematopoietic stem cells. Ann. NY Acad. Sci.
872:57–66.
Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997.
Green mice as a source of ubiquitous green cells. FEBS Lett. 407:313–319.
Ohtsuka, Y., K. Udaka, Y. Yamashiro, H. Yagita, and K. Okumura. 1998. Dystro-
phin acts as a transplantation rejection antigen in dystrophin-deficient mice:
implication for gene therapy. J. Immunol. 160:4635–4640.
Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi. 1996. Long-term lympho-
hematopoietic reconstitution by a single CD34-low/negative hematopoietic
stem cell. Science. 273:242–245.
Partridge, T.A., J.E. Morgan, G.R. Coulton, E.P. Hoffman, and L.M. Kunkel.
1989. Conversion of mdx myofibers from dystrophin-negative to -positive
by injection of normal myoblasts. Nature. 337:176–179.
Partridge, T.A. 1991. Myoblast transfer: a possible therapy for inherited myopa-
thies? Muscle Nerve. 14:197–212.
Pavlath, G.K., T.A. Rando, and H.M. Blau. 1994. Transient immunosuppressive
treatment leads to long-term retention of allogeneic myoblasts in hybrid
myofibers. J. Cell Biol. 127:1923–1932.
Qu, Z., and J. Huard. 2000. Matching host muscle and donor myoblast for myosin
heavy chain improves myoblast transfer therapy. Gene Ther. 7:428–437.
Qu, Z., L. Balkir, J.C.T. van Deutekom, P.D. Robbins, R. Pruchnic, and J.
Huard. 1998. Development of approaches to improve cell survival in myo-
blast transfer therapy. J. Cell Biol. 142:1257–1267.
Rando, T.A., and H.M. Blau. 1994. Primary mouse myoblast purification, charac-
terization, and transplantation for cell-mediated gene therapy. J. Cell Biol.
125:1275–1287.
Rantanen, J., T. Hurme, R. Lukka, J. Heino, and H. Kalimo. 1995. Satellite cell
proliferation and the expression of myogenin and desmin in regenerating
skeletal muscle: evidence for two different populations of satellite cells. Lab.
Invest. 72:341–347.
Richler, C., and D. Yaffe. 1970. The in vitro cultivation and differentiation capaci-
ties of myogenic cell lines. Dev. Biol. 23:1–22.
Rohwedel, J., V. Horak, M. Hebrok, E.M. Fuchtbauer, and A.M. Wobus. 1995.
M-twist expression inhibits mouse embryonic stem cell-derived myogenic
differentiation in vitro. Exp. Cell Res. 220:92–100.
Roy, R., G. Dansereau, J.P. Tremblay, M. Belles-Isles, J. Huard, C. Labrecque, and
J.P. Bouchard. 1991. Expression of major histocompatibility complex anti-
gens on human myoblasts. Transplant. Proc. 23:799–801.
Sanes, J.R., J.L.R. Rubenstein, and J.F. Nicolas. 1986. Use of a recombinant retro-
virus to study post-implantation cell lineage in mouse embryos. EMBO J.
5:5133–5142.
Sato, T., J.H. Laver, and M. Ogawa. 1999. Reversible expression of CD34 by mu-
rine hematopoietic stem cells. Blood. 94:2548–2554.
Seale, P., L.A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, and M.A.
Rudnicki. 2000. Pax7 is required for the specification of myogenic satellite
cells. Cell. 102:777–786.
Schultz, E. 1996. Satellite cell proliferative compartments in growing skeletal mus-
cles. Dev. Biol. 175:84–94.
Schultz, E., and K.M. McCormick. 1994. Skeletal muscle satellite cells. Rev. Phys-
iol. Biochem. Pharmacol. 123:213–257.
Schultz, E., D.L. Jaryszak, and C.R. Valliere. 1985. Response of satellite cells to fo-
cal skeletal muscle injury. Muscle Nerve. 8:217–222.
Skuk, D., M. Goulet, B. Roy, and J.P. Tremblay. 2000. Myoblast transplantation in
whole muscle of nonhuman primates. J. Neuropathol. Exp. Neurol. 59:197–206.
Smith, J., and P.N. Schofield. 1997. Stable integration of an mdx skeletal muscle
cell line into dystrophic (mdx) skeletal muscle: evidence for stem cell status.
Cell Growth Differ. 8:927–934.
Smythe, G.M., S.I. Hodgetts, and M.D. Grounds. 2000. Immunobiology and the
future of myoblast transfer therapy. Mol. Ther. 1:304–313.
Sprinkle, T.J., F.A. McMorris, J. Yoshino, and G.H. DeVries. 1985. Differential
expression of 2’:3 -cyclic nucleotide 3 -phosphodiesterase in cultured cen-
tral, peripheral, and extraneural cells. Neurochem. Res. 10:919–931.
Stockdale, F.E. 1990. The myogenic cell lineage–evidence for multiple cellular pre-
cursors during avian limb development. Proc. Soc. Exp. Biol. Med. 194:71–75.
Tremblay, J.P., F. Malouin, R. Roy, J. Huard, J.P. Bouchard, A. Satoh, and C.L.
Richards. 1993. Results of a triple blind clinical study of myoblast transplan-
tations with immunosuppressive treatment in young boys with Duchenne
muscular dystrophy. Cell Transplant. 2:99–112.
Vilquin, J.T., E. Wagner, I. Kinoshita, R. Roy, and J.P. Tremblay. 1995. Success-
ful histocompatible myoblast transplantation in dystrophin-deficient mdx
mouse despite the production of antibodies against dystrophin. J. Cell Biol.
131:975–988.
Wenger, S.L., W.L. Golden, S.P. Dennis, and M.W. Steele. 1984. Are the occa-
sional aneuploid cells in peripheral blood cultures significant? Am. J. Med.
Genet. 19:715–719.
Yang, Q., R. Bassel-Duby, and R.S. Williams. 1997. Transient expression of a
winged-helix protein, MNF-beta, during myogenesis. Mol. Cell. Biol. 17:
5236–5243.
Young, H.E., T.A. Steele, R.A. Bray, J. Hudson, J.A. Floyd, K. Hawkins, K.
Thomas, T. Austin, C. Edwards, J. Cuzzourt, et al. 2001a. Human reserve
pluripotent mesenchymal stem cells are present in the connective tissues of
skeletal muscle and dermis derived from fetal, adult, and geriatric donors.
Anat. Rec. 264:51–62.
Young, H.E., C. Duplaa, T.M. Young, J.A. Floyd, M.L. Reeves, K.H. Davis, G.J.
Mancini, M.E. Eaton, J.D. Hill, K. Thomas, et al. 2001b. Clonogenic anal-
ysis reveals reserve stem cells in postnatal mammals: I. Pluripotent mesen-
chymal stem cells. Anat. Rec. 263:350–360.